Cargando…

The CD40 agonistic monoclonal antibody APX005M has potent immune stimulatory capabilities

Detalles Bibliográficos
Autores principales:	Bjorck, Pia, Filbert, Erin, Zhang, Yongke, Yang, Xiaodong, Trifan, Ovid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649416/ http://dx.doi.org/10.1186/2051-1426-3-S2-P198

Ejemplares similares

APX005M, a CD40 agonist antibody with unique epitope specificity and Fc receptor binding profile for optimal therapeutic application
por: Filbert, Erin L., et al.
Publicado: (2021)

EPCT-02. PBTC-051: FIRST IN PEDIATRICS PHASE 1 STUDY OF CD40 AGONISTIC MONOCLONAL ANTIBODY APX005M IN PEDIATRIC SUBJECTS WITH RECURRENT/REFRACTORY BRAIN TUMORS
por: Lindsay, Holly, et al.
Publicado: (2020)

Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia
por: Delgado, Raquel, et al.
Publicado: (2021)

Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity
por: Redmond, William L, et al.
Publicado: (2013)

Development of Actinobacillus pleuropneumoniae ApxI, ApxII, and ApxIII-specific ELISA methods for evaluation of vaccine efficiency
por: Jung, Myunghwan, et al.
Publicado: (2019)

Co-stimulatory agonists: An insight into the immunotherapy of cancer
por: Pourakbari, Ramin, et al.
Publicado: (2021)

Immunological study of an attenuated Salmonella Typhimurium expressing ApxIA, ApxIIA, ApxIIIA and OmpA of Actinobacillus pleuropneumoniae in a mouse model
por: HUR, Jin, et al.
Publicado: (2015)

Ascorbate Peroxidase Neofunctionalization at the Origin of APX-R and APX-L: Evidence from Basal Archaeplastida
por: Lazzarotto, Fernanda, et al.
Publicado: (2021)

In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris
por: Hager, Christopher L., et al.
Publicado: (2018)

Evaluation of the In Vitro and In Vivo Antifungal Activity of APX001A/APX001 Against Candida auris
por: Larkin, Emily, et al.
Publicado: (2017)

Chloroplast Thylakoidal Ascorbate Peroxidase, PtotAPX, Has Enhanced Resistance to Oxidative Stress in Populus tomentosa
por: Li, Conghui, et al.
Publicado: (2022)

In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus
por: Shaw, Karen Joy, et al.
Publicado: (2018)

Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in mice
por: Shin, Sung Jae, et al.
Publicado: (2007)

Elucidating the role of ApxI in hemolysis and cellular damage by using a novel apxIA mutant of Actinobacillus pleuropneumoniae serotype 10
por: Chang, Nai-Yun, et al.
Publicado: (2014)

Anti-human CD40 monoclonal antibody therapy is potent without FcR crosslinking
por: Richman, Lee P, et al.
Publicado: (2014)

Evaluation of crystalline amino acids as potent stimulatory chemoattractants for the slipper lobster Thenus orientalis
por: Teoh, Chui-Fen, et al.
Publicado: (2023)

Sero- and apx-typing of German Actinobacillus pleuropneumoniae field isolates from 2010 to 2019 reveals a predominance of serovar 2 with regular apx-profile
por: Schuwerk, Lukas, et al.
Publicado: (2021)

TLR Agonists for Cancer Immunotherapy: Tipping the Balance between the Immune Stimulatory and Inhibitory Effects
por: Lu, Hailing
Publicado: (2014)

TNF‐α has both stimulatory and inhibitory effects on mouse monocyte‐derived osteoclastogenesis
por: Cao, Yixuan, et al.
Publicado: (2017)

A new standard nomenclature for proteins related to Apx and Shroom
por: Hagens, Olivier, et al.
Publicado: (2006)

APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2019)

OsAPX1 Positively Contributes to Rice Blast Resistance
por: Sheng, Cong, et al.
Publicado: (2022)

Efficacy of APX2039 in a Rabbit Model of Cryptococcal Meningitis
por: Giamberardino, Charles D., et al.
Publicado: (2022)

Characterization of a Broadly Reactive Anti-CD40 Agonistic Monoclonal Antibody for Potential Use as an Adjuvant
por: Martin, Cameron, et al.
Publicado: (2017)

CD40 Agonist Monoclonal Antibody-Mediated Hepatitis in TNF-Receptor 1 Gene Knockout Mice
por: Raabe, Oksana, et al.
Publicado: (2021)

Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody
por: Andersson, Hampus, et al.
Publicado: (2023)

Disentangling Capabilities for Industry 4.0 - an Information Systems Capability Perspective
por: Huber, Rocco, et al.
Publicado: (2022)

CCM 87-005
por: Cuperus, J
Publicado: (1987)

DSC 89-005
Publicado: (1989)

Kaolin Foliar Application Has a Stimulatory Effect on Phenylpropanoid and Flavonoid Pathways in Grape Berries
por: Conde, Artur, et al.
Publicado: (2016)

A Novel Monoclonal Antibody Targeting Cancer-Specific Plectin Has Potent Antitumor Activity in Ovarian Cancer
por: Perez, Samantha M., et al.
Publicado: (2021)

Investigating the expression pattern of the OsAPx1 gene promoter in rice
por: Garighan, Julio, et al.
Publicado: (2014)

Dual regulation of cytosolic ascorbate peroxidase (APX) by tyrosine nitration and S-nitrosylation
por: Begara-Morales, Juan C., et al.
Publicado: (2014)

Efficacy of Oral APX001 in a Murine Model of Cryptococcal Meningitis
por: Schell, Wiley A, et al.
Publicado: (2017)

Differential Effects of Inhibitory and Stimulatory Anti-HER2 Monoclonal Antibodies on AKT/ERK Signaling Pathways
por: Soltantoyeh, Tahereh, et al.
Publicado: (2018)

B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes
Publicado: (1987)

Discovery of Kynurenines Containing Oligopeptides as Potent Opioid Receptor Agonists
por: Szűcs, Edina, et al.
Publicado: (2020)

A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents
por: Luo, Jian, et al.
Publicado: (2012)

Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment
por: Van Audenaerde, Jonas RM, et al.
Publicado: (2020)

Genetic Transformation and Analysis of Rice OsAPx2 Gene in Medicago sativa
por: Guan, Qingjie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uotlmt5q57lqruq9c403m4cn7m